Reiter Gregor S, Krivit Jenna, Ye Run Zhou, Iezzi Raymond
Department of Ophthalmology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
Int J Retina Vitreous. 2025 Jul 31;11(1):88. doi: 10.1186/s40942-025-00709-x.
To describe outcomes for internal microneedle drainage for the management of residual subretinal fluid (SRF) during pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD).
Retrospective review of patients undergoing PPV for RRD using a 40-gauge angled and beveled microneedle (Incyto, South Korea) for the aspiration and drainage of SRF during fluid/air exchange. The microneedle is inserted through the neurosensory retina into the bleb of residual SRF, removed from the subretinal space and placed onto the retina or adjacent to the subretinal entry site. Visual acuity (VA) and safety outcomes are reported.
Thirteen eyes from 13 patients with a median age (Q1 - Q3) of 61.12 (52.03-63.81) were included. Median visual acuity (VA) at baseline was 0.52 (0.24-0.8) logMAR (approx. 20/66) and significantly improved to 0.1 (0.02-0.26) logMAR (approx. 20/25) at the last available follow-up time point (p = 0.0167). Macula-off RRD had significantly worse VA at baseline 0.58 (0.3-1.0) logMAR (approx. 20/76) compared to macula-on RRD 0.15 (0.105-0.25) logMAR (approx. 20/28), p = 0.0196) but improved significantly to the last available follow-up (p = 0.0391), matching those with macula-on RRD. The use of microneedle drainage was safe and resulted in an attached retina in all 13 (100%) cases without adverse events.
Microneedle drainage is safe, while patient outcomes are excellent. The complete aspiration of SRF might reduce complications associated with PPV for RRD and optimize visual outcomes.
描述在孔源性视网膜脱离(RRD)的玻璃体切割术(PPV)中,使用内部微针引流处理残余视网膜下液(SRF)的效果。
回顾性分析接受PPV治疗RRD的患者,在液/气交换过程中使用40号有角度和斜面的微针(韩国Incyto公司)抽吸和引流SRF。微针穿过神经感觉视网膜插入残余SRF的泡内,从视网膜下间隙取出并放置在视网膜上或视网膜下入口部位附近。报告视力(VA)和安全性结果。
纳入13例患者的13只眼,中位年龄(Q1 - Q3)为61.12(52.03 - 63.81)岁。基线时中位视力(VA)为0.52(0.24 - 0.8)logMAR(约20/66),在最后一次可获得的随访时间点显著改善至0.1(0.02 - 0.26)logMAR(约20/25)(p = 0.0167)。黄斑脱离的RRD在基线时视力明显较差,为0.58(0.3 - 1.0)logMAR(约20/76),而黄斑未脱离的RRD为0.15(0.105 - 0.25)logMAR(约20/28),p = 0.0196),但在最后一次可获得的随访时显著改善(p = 0.0391),与黄斑未脱离的RRD患者相当。使用微针引流是安全的,所有13例(100%)患者的视网膜均复位,无不良事件发生。
微针引流是安全的,患者预后良好。完全抽吸SRF可能减少RRD的PPV相关并发症并优化视力结果。